The placenta and breast milk both leave the same gaps. A newborn arrives with about a tenth of the mother's vitamin K, and the gut bacteria that make more won't arrive for weeks 1. Breast milk carries almost none. So the clotting factors run near empty in exactly the weeks the umbilical stump separates and small scrapes should stop bleeding.
Vitamin D is the same setup, different plumbing. The baby's level is set by the mother's, and most mothers run low 2. Breast milk delivers well under the 400 IU a day infant bones need 3, and the usual source, sun on skin, is off the table for the first six months.
The vitamin K shot is done by hospital staff by default. You opt out of it, not into it.
That's the whole thing. No titration, no monitoring, no bloodwork. The bottle runs ten to fifteen dollars and lasts the year.
What refusing the shot puts on the table. Late vitamin K bleeding is rare, four to ten cases per 100,000 unsupplemented births 5. The shape is what makes it lopsided: thirty to sixty percent bleed inside the skull, about one in five of those babies dies, and most survivors have permanent brain damage 4. The vitamin D failure is slower: bowed legs, a soft skull, a hypocalcemic seizure in the first months 6. Low odds, large harm to any one baby, cheap to prevent.
Two alternatives actually hold up. Oral vitamin K, three doses over the first six weeks, is standard in the Netherlands; it lowers the dangerous late-bleeding risk but doesn't erase it 1. If you're set on refusing the shot, this is the harm-reduction path, so schedule all three before leaving the hospital. And a breastfeeding mother taking 6,400 IU of vitamin D a day gives the baby the same status as the infant drop 2.
The fine print — when to skip it, and what people get wrong
The big fear, that the shot causes leukemia, traces to one 1992 paper 7; every study since found no link 8, 9. "Enough sun" holds only for pale infants above ~35° latitude in summer.
Refusal is the top failure mode, usually the 1992 paper retold without its rebuttals. The drop fails quieter: it drifts once the bottle empties and the baby looks fine. You can't tell a protected baby from a lucky one by looking.
- 1Sankar MJ et al. (2016). Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review. Journal of Perinatology. link
- 2Hollis BW et al. (2015). Maternal versus infant vitamin D supplementation during lactation: a randomized controlled trial. Pediatrics. link
- 3Wagner CL, Greer FR (2008). Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. link
- 4Hand I et al. (2022). Vitamin K and the newborn infant (AAP Committee on Fetus and Newborn policy statement). Pediatrics. link
- 5Sutor AH et al. (1995). Vitamin K deficiency bleeding (VKDB) in infancy. Thrombosis and Haemostasis. link
- 6Misra M et al. (2008). Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. link
- 7Golding J et al. (1992). Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ. link
- 8Fear NT et al. (2003). Vitamin K and childhood cancer: a report from the United Kingdom Childhood Cancer Study. British Journal of Cancer. link
- 9Roman E et al. (2002). Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. British Journal of Cancer. link
Newborn Vitamin K and Vitamin D
Vitamin D drops retail $10-15 for a ~1-year supply at 400 IU/day. The vitamin K shot is bundled with the delivery bill and is functionally free at the margin.
One IM dose administered by hospital staff at birth; daily oral drop until ~12 months. Drop administration is a few seconds folded into a feed (onto the nipple or into the corner of the mouth).
Cochrane review (Puckett & Offringa 2000); large-scale national surveillance data (Sutor 1995, Sankar 2016); AAP / WHO / NICE / RCPCH / Endocrine Society guideline consensus over decades; Hollis 2015 RCT for the maternal-supplementation alternative. The historical cancer-association concern (Golding 1992) has been refuted by multiple independent case-control studies (Parker 1998, McKinney 1998, Roman 2002, Fear 2003).
Universal IM vitamin K eliminates late VKDB (incidence ~4-10/100,000 without prophylaxis, with ~20% case-fatality and major neurological sequelae in survivors; Sutor 1995, Hand 2022). 400 IU/day vitamin D prevents nutritional rickets and hypocalcemic seizures in exclusively breastfed infants (Wagner & Greer 2008, Misra 2008). Meaningful but absolute-rate-bounded mortality and disability reduction.
Maintains adequate clotting-factor activity and calcium-driven bone mineralization in the newborn window when both substrates are otherwise depleted (low placental vitamin K transfer, low breast milk vitamin D). Felt change is null in well-supported infants; the substance scores low here because its work is preventive, not enhancing.